Form D · Biotechnology
Gennao Bio, Inc.
Pennington, NJ · CIK 0001862102
Offering snapshot reported Dec 8, 2022 · SEC filing
- Reported sold
- $15M Offering amount: $40M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 28, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 8, 2022 | Initial | $14,999,997 | No comparison | 3 | SEC filing |
| Dec 28, 2021 | Amendment | $32,500,008 | $22,500,003vs May 21, 2021 | 7 | SEC filing |
| May 21, 2021 | Initial | $10,000,005 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-466966
Series B Preferred Stock
Source: Form D, filed Dec 8, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Bradley Campbell | Director |
| Chris Duke | Executive |
| Craig Gordon | Director |
| Anuj Goswami | Executive |
| Julie Hambleton | Director |
| Chau Khuong | Director |
| Dale Ludwig | Executive |
| Joe Mc Intosh | Executive |
| Claudine Prowse | Executive |
| Gary Sender | Director |
| Stephen Squinto | Director, Executive, Promoter |
| Peter Thompson | Director |
| Bruce Turner | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
311 Pennington Rocky Hill Road Building #21
Pennington, NJ, 08534
Pennington, NJ, 08534